FibroScan is a new type of non-invasive liver fibrosis detection device. It is the world's first and only one that is completely non-invasive to diagnose and monitor chronic liver disease by quantifying the liver hardness Real-time testing equipment.
The device is easy to use and reliable, can reduce the pain of liver disease patients, and make a more accurate judgment on the degree of liver fibrosis caused by various causes of chronic liver disease.
Compared with the traditional liver puncture detection method, it has the advantages of accurate classification, no trauma and pain, and can greatly reduce the patient's examination cost.
At present, FibroScan has been widely used in Asia and many other countries and regions. Thanks to FibroScan it is possible to know how much the liver disease from which the patient is affected is more or less close to hesitating in cirrhosis.
A large number of clinical trials have fully validated FibroScan for the diagnosis and evaluation of hepatitis C, hepatitis B and other liver diseases, and it has been confirmed that FibroScan has a very high accuracy for the staged diagnosis of liver fibrosis.
Fibro Scan test can accurately detect liver fibrosis, and the higher the degree of liver fibrosis, the higher the accuracy. In addition, the experience of most doctors proves that using FibroScan to diagnose liver fibrosis can avoid liver biopsy in more than 75% of patients, and can greatly improve the detection rate of liver cirrhosis.
A useful test tool for the evaluation of the therapeutic efficacy of patients with chronic liver disease. The existing research results show that FibroScan has a good diagnostic effect in the diagnosis of liver fibrosis and cirrhosis caused by various chronic liver diseases (viral hepatitis, alcoholic hepatitis, non-alcoholic steatohepatitis, and autoimmune liver disease).
Due to the shortcomings of liver biopsy, there is an urgent need for a non-invasive and painless diagnosis method for liver fibrosis.
In fact, FibroScan's diagnostic accuracy is very high, not only can be used to screen fibrosis and cirrhosis of patients with severe viral liver disease, but also for other liver diseases.
A large number of independent clinical studies have confirmed that FibroScan has a wide range of applications, such as patients under treatment, patients with hemophilia, drug addicts, liver transplanters, etc.
When liver biopsy is not available, such as screening for cirrhosis in the normal population, helping alcoholics get rid of addiction, evaluating new anti-fibrosis methods, and even finding to define severe subtypes of liver cirrhosis, etc., FibroScan test can be used in the above.
The field provides valuable assistance to doctors and patients.
The wide application of this tool can promote the rapid improvement of the liver disease treatment level in the country, and it has far-reaching social significance for the development of medical technology and the relief of patient suffering.
Fibroscan test is an outpatient procedure that lasts a maximum of 15 minutes, completely painless, easily repeatable over time, inexpensive.
It is an easily executable test that takes 5 minutes to make at least 10 measurements. By changing the position of the probe, on the chosen intercostal space, different measurements of the hardness of the explored liver can be made.
Until now, this information was obtainable only with a liver biopsy that is to say with a sampling from the liver, performed under local anesthesia, with a special needle.
Liver biopsy is not loved by patients because it is sometimes unpleasant and in any case invasive; moreover, when the fragment of tissue that the hepatologist obtains with the biopsy is small, it may not faithfully represent the state of the liver in its entirety. It commonly requires day hospitalization.